The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification

Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect colistin resistance acquisition on the innate immune response. We used a pair of ST11 clone Klebsiella pneumoniae strains: an OXA-48, CTX-M-15 K. pneumoniae strain susceptible t...

Full description

Saved in:
Bibliographic Details
Published in:Infection and immunity Vol. 91; no. 2; p. e0001223
Main Authors: Avendaño-Ortiz, José, Ponce-Alonso, Manuel, Llanos-González, Emilio, Barragán-Prada, Hugo, Barbero-Herranz, Raquel, Lozano-Rodríguez, Roberto, Márquez-Garrido, Francesc J, Hernández-Pérez, José María, Morosini, María-Isabel, Cantón, Rafael, Del Campo, Rosa, López-Collazo, Eduardo
Format: Journal Article
Language:English
Published: United States American Society for Microbiology 16-02-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect colistin resistance acquisition on the innate immune response. We used a pair of ST11 clone Klebsiella pneumoniae strains: an OXA-48, CTX-M-15 K. pneumoniae strain susceptible to colistin (CS-Kp) isolated from a urinary infection and its colistin-resistant variant (CR-Kp) from the same patient after prolonged treatment with colistin. No mutation of previously described genes for colistin resistance ( , , , , and ) was found in the CR-Kp genome; however, LPS modifications were characterized by negative-ion matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. The strains were cocultured with human monocytes to determine their survival after phagocytosis and induction to apoptosis. Also, monocytes were stimulated with bacterial LPS to study cytokine and immune checkpoint production. The addition of 4-amino-4-deoxy-l-arabinose (Ara4N) to lipid A of CR-Kp accounted for the colistin resistance. CR-Kp survived significantly longer inside human monocytes after being phagocytosed than did the CS-Kp strain. In addition, LPS from CR-Kp induced both higher apoptosis in monocytes and higher levels of cytokine and immune checkpoint production than LPS from CS-Kp. Our data reveal a variable impact of colistin resistance on the innate immune system, depending on the responsible mechanism. Adding Ara4N to LPS in K. pneumoniae increases bacterial survival after phagocytosis and elicits a higher inflammatory response than its colistin-susceptible counterpart.
AbstractList Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect in vivo colistin resistance acquisition on the innate immune response. We used a pair of ST11 clone Klebsiella pneumoniae strains: an OXA-48, CTX-M-15 K. pneumoniae strain susceptible to colistin (CS-Kp) isolated from a urinary infection and its colistin-resistant variant (CR-Kp) from the same patient after prolonged treatment with colistin. No mutation of previously described genes for colistin resistance (pmrA, pmrB, mgrB, phoP/Q, arnA, arnC, arnT, ugdH, and crrAB) was found in the CR-Kp genome; however, LPS modifications were characterized by negative-ion matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry. The strains were cocultured with human monocytes to determine their survival after phagocytosis and induction to apoptosis. Also, monocytes were stimulated with bacterial LPS to study cytokine and immune checkpoint production. The addition of 4-amino-4-deoxy-l-arabinose (Ara4N) to lipid A of CR-Kp accounted for the colistin resistance. CR-Kp survived significantly longer inside human monocytes after being phagocytosed than did the CS-Kp strain. In addition, LPS from CR-Kp induced both higher apoptosis in monocytes and higher levels of cytokine and immune checkpoint production than LPS from CS-Kp. Our data reveal a variable impact of colistin resistance on the innate immune system, depending on the responsible mechanism. Adding Ara4N to LPS in K. pneumoniae increases bacterial survival after phagocytosis and elicits a higher inflammatory response than its colistin-susceptible counterpart.
Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect colistin resistance acquisition on the innate immune response. We used a pair of ST11 clone Klebsiella pneumoniae strains: an OXA-48, CTX-M-15 K. pneumoniae strain susceptible to colistin (CS-Kp) isolated from a urinary infection and its colistin-resistant variant (CR-Kp) from the same patient after prolonged treatment with colistin. No mutation of previously described genes for colistin resistance ( , , , , and ) was found in the CR-Kp genome; however, LPS modifications were characterized by negative-ion matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. The strains were cocultured with human monocytes to determine their survival after phagocytosis and induction to apoptosis. Also, monocytes were stimulated with bacterial LPS to study cytokine and immune checkpoint production. The addition of 4-amino-4-deoxy-l-arabinose (Ara4N) to lipid A of CR-Kp accounted for the colistin resistance. CR-Kp survived significantly longer inside human monocytes after being phagocytosed than did the CS-Kp strain. In addition, LPS from CR-Kp induced both higher apoptosis in monocytes and higher levels of cytokine and immune checkpoint production than LPS from CS-Kp. Our data reveal a variable impact of colistin resistance on the innate immune system, depending on the responsible mechanism. Adding Ara4N to LPS in K. pneumoniae increases bacterial survival after phagocytosis and elicits a higher inflammatory response than its colistin-susceptible counterpart.
Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect in vivo colistin resistance acquisition on the innate immune response. Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect in vivo colistin resistance acquisition on the innate immune response. We used a pair of ST11 clone Klebsiella pneumoniae strains: an OXA-48, CTX-M-15 K. pneumoniae strain susceptible to colistin (CS-Kp) isolated from a urinary infection and its colistin-resistant variant (CR-Kp) from the same patient after prolonged treatment with colistin. No mutation of previously described genes for colistin resistance ( pmrA , pmrB , mgrB , phoP/Q, arnA, arnC, arnT, ugdH , and crrAB ) was found in the CR-Kp genome; however, LPS modifications were characterized by negative-ion matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry. The strains were cocultured with human monocytes to determine their survival after phagocytosis and induction to apoptosis. Also, monocytes were stimulated with bacterial LPS to study cytokine and immune checkpoint production. The addition of 4-amino-4-deoxy- l -arabinose (Ara4N) to lipid A of CR-Kp accounted for the colistin resistance. CR-Kp survived significantly longer inside human monocytes after being phagocytosed than did the CS-Kp strain. In addition, LPS from CR-Kp induced both higher apoptosis in monocytes and higher levels of cytokine and immune checkpoint production than LPS from CS-Kp. Our data reveal a variable impact of colistin resistance on the innate immune system, depending on the responsible mechanism. Adding Ara4N to LPS in K. pneumoniae increases bacterial survival after phagocytosis and elicits a higher inflammatory response than its colistin-susceptible counterpart.
Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect in vivo colistin resistance acquisition on the innate immune response. We used a pair of ST11 clone Klebsiella pneumoniae strains: an OXA-48, CTX-M-15 K. pneumoniae strain susceptible to colistin (CS-Kp) isolated from a urinary infection and its colistin-resistant variant (CR-Kp) from the same patient after prolonged treatment with colistin. No mutation of previously described genes for colistin resistance ( pmrA , pmrB , mgrB , phoP/Q, arnA, arnC, arnT, ugdH , and crrAB ) was found in the CR-Kp genome; however, LPS modifications were characterized by negative-ion matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry. The strains were cocultured with human monocytes to determine their survival after phagocytosis and induction to apoptosis. Also, monocytes were stimulated with bacterial LPS to study cytokine and immune checkpoint production. The addition of 4-amino-4-deoxy- l -arabinose (Ara4N) to lipid A of CR-Kp accounted for the colistin resistance. CR-Kp survived significantly longer inside human monocytes after being phagocytosed than did the CS-Kp strain. In addition, LPS from CR-Kp induced both higher apoptosis in monocytes and higher levels of cytokine and immune checkpoint production than LPS from CS-Kp. Our data reveal a variable impact of colistin resistance on the innate immune system, depending on the responsible mechanism. Adding Ara4N to LPS in K. pneumoniae increases bacterial survival after phagocytosis and elicits a higher inflammatory response than its colistin-susceptible counterpart.
Author Ponce-Alonso, Manuel
Morosini, María-Isabel
Cantón, Rafael
López-Collazo, Eduardo
Hernández-Pérez, José María
Márquez-Garrido, Francesc J
Del Campo, Rosa
Barragán-Prada, Hugo
Barbero-Herranz, Raquel
Llanos-González, Emilio
Avendaño-Ortiz, José
Lozano-Rodríguez, Roberto
Author_xml – sequence: 1
  givenname: José
  orcidid: 0000-0003-2774-1821
  surname: Avendaño-Ortiz
  fullname: Avendaño-Ortiz, José
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 2
  givenname: Manuel
  orcidid: 0000-0002-3239-9373
  surname: Ponce-Alonso
  fullname: Ponce-Alonso, Manuel
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 3
  givenname: Emilio
  orcidid: 0000-0001-9449-2226
  surname: Llanos-González
  fullname: Llanos-González, Emilio
  organization: Grupo de Estrés Oxidativo y Neurodegeneración, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Ciudad Real, Spain
– sequence: 4
  givenname: Hugo
  surname: Barragán-Prada
  fullname: Barragán-Prada, Hugo
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 5
  givenname: Raquel
  surname: Barbero-Herranz
  fullname: Barbero-Herranz, Raquel
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 6
  givenname: Roberto
  orcidid: 0000-0003-0093-9707
  surname: Lozano-Rodríguez
  fullname: Lozano-Rodríguez, Roberto
  organization: Grupo Respuesta Inmune Innata, IdiPAZ, Hospital Universitario de la Paz, Madrid, Spain
– sequence: 7
  givenname: Francesc J
  surname: Márquez-Garrido
  fullname: Márquez-Garrido, Francesc J
  organization: Bruker Española S.A., Madrid, Spain
– sequence: 8
  givenname: José María
  surname: Hernández-Pérez
  fullname: Hernández-Pérez, José María
  organization: Instituto de Investigación Germans Trias i Pujol, Badalona, Spain
– sequence: 9
  givenname: María-Isabel
  surname: Morosini
  fullname: Morosini, María-Isabel
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 10
  givenname: Rafael
  orcidid: 0000-0003-1675-3173
  surname: Cantón
  fullname: Cantón, Rafael
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 11
  givenname: Rosa
  orcidid: 0000-0003-1147-7923
  surname: Del Campo
  fullname: Del Campo, Rosa
  organization: CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 12
  givenname: Eduardo
  orcidid: 0000-0003-1957-877X
  surname: López-Collazo
  fullname: López-Collazo, Eduardo
  organization: CIBERES, Instituto de Salud Carlos III, Madrid, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36722977$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1v3CAQhlGVqNkkvfVccWylOAFsg7lUilb5WGmjSNHeEYxxl8gG1-BI--9LsmmUHMIFZnjmnYH3GB344C1C3yk5p5Q1F067c0IIZQUrv6AFJbIp6pqxA7TIWVnImosjdBzjYw6rqmq-oqOSC8akEAvkNluLV8OoIeHQ4WXoXUzO4wcb80F7sDh4nDJ0Cck96eRymMGV9zo9Vw6zd2mHzQ6v3RjG0O-iBtjqybUW34XWdQ5eqk7RYaf7aL-97idoc321Wd4W6_ub1fJyXeiKNqloa8hLGssNb4yhRjBJKCEgKcvzGwNU6rqzbUU4dC3UFTREQCPqSoKx5Qn6vZcdZzPYFqxPk-7VOLlBTzsVtFMfb7zbqj_hSUlZlrzmWeDnq8AU_s42JjW4CLbvtbdhjooJQXnZcCYyerZHYQoxTrZ7a0OJejZHZXPUizmKlRn_tcd1HJh6DPPk80d8xv54_4w34f_Olf8Ai_ycWw
CitedBy_id crossref_primary_10_1016_j_resmic_2023_104049
crossref_primary_10_22207_JPAM_17_4_24
crossref_primary_10_1128_iai_00016_24
Cites_doi 10.1007/s00018-014-1762-5
10.3791/3916
10.1016/S1473-3099(06)70580-1
10.1002/ctm2.573
10.1016/j.smim.2003.10.003
10.1016/j.chembiol.2018.04.003
10.1101/gr.074492.107
10.1128/iai.42.1.170-177.1983
10.1093/bioinformatics/btu153
10.1016/j.ijantimicag.2017.11.011
10.1002/advs.202101336
10.1038/nrclinonc.2017.88
10.1038/s41598-019-53846-3
10.3389/fmed.2021.677720
10.1128/JCM.01427-19
10.3390/biology10050436
10.1128/IAI.00018-20
10.1093/nar/gkac920
10.1016/j.jiac.2022.01.002
10.1038/s41467-017-02149-0
10.1038/nrmicro2295
10.1038/nri.2017.112
10.1097/SHK.0b013e318262c4b0
10.1128/CMR.00064-16
10.1186/s13104-021-05867-3
10.4049/jimmunol.0803350
10.3390/antibiotics6040028
10.1002/chem.201406058
10.1111/j.1469-0691.2011.03734.x
10.1089/cmb.2012.0021
10.1128/IAI.01046-12
10.1073/pnas.1303641110
10.1093/jac/dkx234
10.1371/journal.pone.0029577
10.15252/emmm.201607336
10.1128/AAC.01870-15
10.1016/j.jcf.2018.11.002
10.1159/000514727
10.1016/j.ijantimicag.2016.09.025
10.1038/nrmicro3047
10.1093/infdis/jix279
10.1146/annurev.biochem.71.110601.135414
10.1016/j.diagmicrobio.2018.08.014
10.1038/s41467-022-29206-7
10.1158/2159-8290.CD-18-0367
10.1111/cei.12401
10.1016/j.diagmicrobio.2012.07.010
10.1111/j.1365-2958.2006.05519.x
10.1128/AAC.00952-15
10.1099/mic.0.000827
ContentType Journal Article
Copyright Copyright © 2023 American Society for Microbiology.
Copyright © 2023 American Society for Microbiology. 2023 American Society for Microbiology
Copyright_xml – notice: Copyright © 2023 American Society for Microbiology.
– notice: Copyright © 2023 American Society for Microbiology. 2023 American Society for Microbiology
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1128/iai.00012-23
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-5522
Editor Bäumler, Andreas J.
Editor_xml – sequence: 1
  givenname: Andreas J.
  surname: Bäumler
  fullname: Bäumler, Andreas J.
EndPage e0001223
ExternalDocumentID 10_1128_iai_00012_23
00012-23
36722977
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: MEC | Instituto de Salud Carlos III (ISCIII)
  grantid: PI20/00164
  funderid: https://doi.org/10.13039/501100004587
– fundername: Fundación La Paz-HULP
  grantid: -
– fundername: MEC | Instituto de Salud Carlos III (ISCIII)
  grantid: CD21/00059
  funderid: https://doi.org/10.13039/501100004587
– fundername: MEC | Instituto de Salud Carlos III (ISCIII)
  grantid: CM19/00069
  funderid: https://doi.org/10.13039/501100004587
– fundername: ;
  grantid: PI20/00164
– fundername: ;
  grantid: CD21/00059
– fundername: ;
  grantid: -
– fundername: ;
  grantid: CM19/00069
GroupedDBID ---
-DZ
-~X
.55
0R~
18M
29I
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
ABOCM
ACGFO
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
L7B
NPM
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
SJN
TR2
TWZ
UCJ
UPT
VQA
W2D
W8F
WH7
WOQ
X7M
~KM
AAPBV
ABFLS
ZA5
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-a418t-d5cccc9be6b68bb1b7290100c912014bbc19a5fed406cfdc54c807c87549cbe3
IEDL.DBID RPM
ISSN 0019-9567
IngestDate Tue Sep 17 21:30:59 EDT 2024
Sat Oct 05 04:31:18 EDT 2024
Thu Nov 21 22:35:23 EST 2024
Thu Feb 16 19:45:11 EST 2023
Sat Sep 28 08:09:34 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords monocytes
phagocytosis
antibiotic resistance
inflammation
LPS modification
colistin
immune checkpoints
Language English
License All Rights Reserved. https://doi.org/10.1128/ASMCopyrightv2
All Rights Reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a418t-d5cccc9be6b68bb1b7290100c912014bbc19a5fed406cfdc54c807c87549cbe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
José Avendaño-Ortiz and Manuel Ponce-Alonso have contributed equally to this work. Author order was determined by total implication in manuscript writing.
The authors declare no conflict of interest.
ORCID 0000-0003-1147-7923
0000-0002-3239-9373
0000-0003-1675-3173
0000-0001-9449-2226
0000-0003-0093-9707
0000-0003-2774-1821
0000-0003-1957-877X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933656
PMID 36722977
PQID 2771638627
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9933656
proquest_miscellaneous_2771638627
crossref_primary_10_1128_iai_00012_23
asm2_journals_10_1128_iai_00012_23
pubmed_primary_36722977
PublicationCentury 2000
PublicationDate 2023-02-16
PublicationDateYYYYMMDD 2023-02-16
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-16
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Infection and immunity
PublicationTitleAbbrev Infect Immun
PublicationTitleAlternate Infect Immun
PublicationYear 2023
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References Barragán-Prada, H, Ruiz-Hueso, P, Tedim, AP, González-Candelas, F, Galán, JC, Cantón, R, Morosini, M-I (B32) 2019; 93
Rezania, S, Amirmozaffari, N, Tabarraei, B, Jeddi-Tehrani, M, Zarei, O, Alizadeh, R, Masjedian, F, Zarnani, AH (B50) 2011; 3
Avendaño-Ortiz, J, Maroun-Eid, C, Martín-Quirós, A, Toledano, V, Cubillos-Zapata, C, Gómez-Campelo, P, Varela-Serrano, A, Casas-Martin, J, Llanos-González, E, Alvarez, E, García-Río, F, Aguirre, LA, Hernández-Jiménez, E, López-Collazo, E (B28) 2018; 217
Diacovich, L, Gorvel, J-P (B15) 2010; 8
Mattiuz, G, Nicolò, S, Antonelli, A, Giani, T, Baccani, I, Cannatelli, A, Clemente, AM, Castronovo, G, Tanturli, M, Cozzolino, F, Rossolini, GM, Torcia, MG (B23) 2020; 88
Avendaño-Ortiz, J, Lozano-Rodríguez, R, Martín-Quirós, A, Terrón, V, Maroun-Eid, C, Montalbán-Hernández, K, Valentín-Quiroga, J, García-Garrido, MÁ, Del Val, EM, Del Balzo-Castillo, Á, Peinado, M, Gómez, L, Herrero-Benito, C, Rubio, C, Casalvilla-Dueñas, JC, Gómez-Campelo, P, Pascual-Iglesias, A, Del Fresno, C, Aguirre, LA, López-Collazo, E (B41) 2021; 11
Cordero, M, García-Fernández, J, Acosta, IC, Yepes, A, Avendano-Ortiz, J, Lisowski, C, Oesterreicht, B, Ohlsen, K, Lopez-Collazo, E, Förstner, KU, Eulalio, A, Lopez, D (B52) 2022; 13
Fayad, AA, Herrmann, J, Müller, R (B10) 2018; 25
Needham, BD, Trent, MS (B16) 2013; 11
Seemann, T (B46) 2014; 30
Tietgen, M, Semmler, T, Riedel-Christ, S, Kempf, VAJ, Molinaro, A, Ewers, C, Göttig, S (B14) 2018; 51
Hancock, RE, Mutharia, LM, Chan, L, Darveau, RP, Speert, DP, Pier, GB (B19) 1983; 42
Płóciennikowska, A, Hromada-Judycka, A, Borzęcka, K, Kwiatkowska, K (B17) 2015; 72
Cullen, TW, O’Brien, JP, Hendrixson, DR, Giles, DK, Hobb, RI, Thompson, SA, Brodbelt, JS, Trent, MS (B24) 2013; 81
Martín-Quirós, A, Maroun-Eid, C, Avendaño-Ortiz, J, Lozano-Rodríguez, R, Valentín Quiroga, J, Terrón, V, Montalbán-Hernández, K, García-Garrido, MA, Muñoz del Val, E, del Balzo-Castillo, Á, Rubio, C, Cubillos-Zapata, C, Aguirre, LA, López-Collazo, E (B42) 2021; 6
Yahav, D, Farbman, L, Leibovici, L, Paul, M (B4) 2012; 18
Zerbino, DR, Birney, E (B44) 2008; 18
Gogry, FA, Siddiqui, MT, Sultan, I, Haq, QMR (B5) 2021; 8
Hollaus, R, Ittig, S, Hofinger, A, Haegman, M, Beyaert, R, Kosma, P, Zamyatina, A (B26) 2015; 21
Paciello, I, Silipo, A, Lembo-Fazio, L, Curcurù, L, Zumsteg, A, Noël, G, Ciancarella, V, Sturiale, L, Molinaro, A, Bernardini, ML (B20) 2013; 110
Avendaño-Ortiz, J, Llanos-González, E, Toledano, V, Del Campo, R, Cubillos-Zapata, C, Lozano-Rodríguez, R, Ismail, A, Prados, C, Gómez-Campelo, P, Aguirre, LA, García-Río, F, López-Collazo, E (B27) 2019; 18
Yang, Q, Li, M, Spiller, OB, Andrey, DO, Hinchliffe, P, Li, H, MacLean, C, Niumsup, P, Powell, L, Pritchard, M, Papkou, A, Shen, Y, Portal, E, Sands, K, Spencer, J, Tansawai, U, Thomas, D, Wang, S, Wang, Y, Shen, J, Walsh, T (B13) 2017; 8
Davis, MR, Goldberg, JB (B49) 2012
Bradford, PA, Kazmierczak, KM, Biedenbach, DJ, Wise, MG, Hackel, M, Sahm, DF (B6) 2015; 60
Pal, S, Verma, J, Mallick, S, Rastogi, SK, Kumar, A, Ghosh, AS (B34) 2019; 165
Bankevich, A, Nurk, S, Antipov, D, Gurevich, AA, Dvorkin, M, Kulikov, AS, Lesin, VM, Nikolenko, SI, Pham, S, Prjibelski, AD, Pyshkin, AV, Sirotkin, AV, Vyahhi, N, Tesler, G, Alekseyev, MA, Pevzner, PA (B45) 2012; 19
Alcock, BP, Huynh, W, Chalil, R, Smith, KW, Raphenya, AR, Wlodarski, MA, Edalatmand, A, Petkau, A, Syed, SA, Tsang, KK, Baker, SJC, Dave, M, McCarthy, MC, Mukiri, KM, Nasir, JA, Golbon, B, Imtiaz, H, Jiang, X, Kaur, K, Kwong, M, Liang, ZC, Niu, KC, Shan, P, Yang, JYJ, Gray, KL, Hoad, GR, Jia, B, Bhando, T, Carfrae, LA, Farha, MA, French, S, Gordzevich, R, Rachwalski, K, Tu, MM, Bordeleau, E, Dooley, D, Griffiths, E, Zubyk, HL, Brown, ED, Maguire, F, Beiko, RG, Hsiao, WWL, Brinkman, FSL, Van Domselaar, G, McArthur, AG (B48) 2023; 51
Bergen, PJ, Landersdorfer, CB, Zhang, J, Zhao, M, Lee, HJ, Nation, RL, Li, J (B2) 2012; 74
Leung, LM, Cooper, VS, Rasko, DA, Guo, Q, Pacey, MP, McElheny, CL, Mettus, RT, Yoon, SH, Goodlett, DR, Ernst, RK, Doi, Y (B30) 2017; 72
B47
Zhao, Z, Jiang, X, Kang, C, Xiao, Y, Hou, C, Yu, J, Wang, R, Xiao, H, Zhou, T, Wen, Z, Feng, J, Chen, G, Ma, Y, Shen, B, Li, Y, Han, G (B43) 2014; 178
Furniss, RCD, Dortet, L, Bolland, W, Drews, O, Sparbier, K, Bonnin, RA, Filloux, A, Kostrzewa, M, Mavridou, DAI, Larrouy-Maumus, G (B31) 2019; 57
Sato, Y, Unno, Y, Miyazaki, C, Ubagai, T, Ono, Y (B36) 2019; 9
Poirel, L, Jayol, A, Nordmann, P (B8) 2017; 30
Masood, KI, Umar, S, Hasan, Z, Farooqi, J, Razzak, SA, Jabeen, N, Rao, J, Shakoor, S, Hasan, R (B9) 2021; 14
Li, J, Nation, RL, Turnidge, JD, Milne, RW, Coulthard, K, Rayner, CR, Paterson, DL (B3) 2006; 6
Wykes, MN, Lewin, SR (B29) 2018; 18
Choi, M-J, Ko, KS (B12) 2015; 59
Urooj, M, Ullah, R, Ali, S, Mohyuddin, A, Mirza, HM, Faryal, R (B35) 2022; 28
Nishino, M, Ramaiya, NH, Hatabu, H, Hodi, FS (B38) 2017; 14
Giamarellou, H (B7) 2016; 48
Dogan, O, Vatansever, C, Atac, N, Albayrak, O, Karahuseyinoglu, S, Sahin, OE, Kilicoglu, BK, Demiray, A, Ergonul, O, Gönen, M, Can, F (B33) 2021; 10
Brett, PJ, Burtnick, MN, Snyder, DS, Shannon, JG, Azadi, P, Gherardini, FC (B37) 2007; 63
del Campo, R, Martínez, E, del Fresno, C, Alenda, R, Gómez-Piña, V, Fernández-Ruíz, I, Siliceo, M, Jurado, T, Toledano, V, Arnalich, F, García-Río, F, López-Collazo, E (B40) 2011; 6
Wei, SC, Duffy, CR, Allison, JP (B39) 2018; 8
Yin, W, Ling, Z, Dong, Y, Qiao, L, Shen, Y, Liu, Z, Wu, Y, Li, W, Zhang, R, Walsh, TR, Dai, C, Li, J, Yang, H, Liu, D, Wang, Y, Gao, GF, Shen, J (B25) 2021; 8
Da Silva, GJ, Domingues, S (B11) 2017; 6
Salomao, R, Brunialti, MKC, Rapozo, MM, Baggio-Zappia, GL, Galanos, C, Freudenberg, M (B18) 2012; 38
del Fresno, C, García-Rio, F, Gómez-Piña, V, Soares-Schanoski, A, Fernández-Ruíz, I, Jurado, T, Kajiji, T, Shu, C, Marín, E, Gutierrez del Arroyo, A, Prados, C, Arnalich, F, Fuentes-Prior, P, Biswas, SK, Biswas, SK, López-Collazo, E (B51) 2009; 182
Takeda, K, Akira, S (B21) 2004; 16
Raetz, CRH, Whitfield, C (B1) 2002; 71
Kidd, TJ, Mills, G, Sá-Pessoa, J, Dumigan, A, Frank, CG, Insua, JL, Ingram, R, Hobley, L, Bengoechea, JA (B22) 2017; 9
e_1_3_3_50_2
e_1_3_3_16_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_33_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_52_2
e_1_3_3_40_2
e_1_3_3_5_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_23_2
e_1_3_3_48_2
e_1_3_3_25_2
e_1_3_3_46_2
e_1_3_3_44_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
Rezania S (e_1_3_3_51_2) 2011; 3
e_1_3_3_17_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_32_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_53_2
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_28_2
e_1_3_3_49_2
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
References_xml – volume: 72
  start-page: 557
  year: 2015
  end-page: 581
  ident: B17
  article-title: Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-014-1762-5
  contributor:
    fullname: Kwiatkowska, K
– start-page: 3916
  issue: (63)
  year: 2012
  ident: B49
  article-title: Purification and visualization of lipopolysaccharide from Gram-negative bacteria by hot aqueous-phenol extraction
  publication-title: J Vis Exp
  doi: 10.3791/3916
  contributor:
    fullname: Goldberg, JB
– volume: 6
  start-page: 589
  year: 2006
  end-page: 601
  ident: B3
  article-title: Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(06)70580-1
  contributor:
    fullname: Paterson, DL
– volume: 11
  year: 2021
  ident: B41
  article-title: The immune checkpoints storm in COVID-19: role as severity markers at emergency department admission
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.573
  contributor:
    fullname: López-Collazo, E
– volume: 16
  start-page: 3
  year: 2004
  end-page: 9
  ident: B21
  article-title: TLR signaling pathways
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2003.10.003
  contributor:
    fullname: Akira, S
– volume: 25
  start-page: 351
  year: 2018
  end-page: 353
  ident: B10
  article-title: Octapeptins: lipopeptide antibiotics against multidrug-resistant superbugs
  publication-title: Cell Chem Biol
  doi: 10.1016/j.chembiol.2018.04.003
  contributor:
    fullname: Müller, R
– volume: 18
  start-page: 821
  year: 2008
  end-page: 829
  ident: B44
  article-title: Velvet: algorithms for de novo short read assembly using de Bruijn graphs
  publication-title: Genome Res
  doi: 10.1101/gr.074492.107
  contributor:
    fullname: Birney, E
– volume: 42
  start-page: 170
  year: 1983
  end-page: 177
  ident: B19
  article-title: Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains
  publication-title: Infect Immun
  doi: 10.1128/iai.42.1.170-177.1983
  contributor:
    fullname: Pier, GB
– volume: 30
  start-page: 2068
  year: 2014
  end-page: 2069
  ident: B46
  article-title: Prokka: rapid prokaryotic genome annotation
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu153
  contributor:
    fullname: Seemann, T
– volume: 51
  start-page: 554
  year: 2018
  end-page: 561
  ident: B14
  article-title: Impact of the colistin resistance gene mcr-1 on bacterial fitness
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2017.11.011
  contributor:
    fullname: Göttig, S
– volume: 8
  start-page: 2101336
  year: 2021
  ident: B25
  article-title: Mobile colistin resistance enzyme MCR-3 facilitates bacterial evasion of host phagocytosis
  publication-title: Adv Sci
  doi: 10.1002/advs.202101336
  contributor:
    fullname: Shen, J
– volume: 14
  start-page: 655
  year: 2017
  end-page: 668
  ident: B38
  article-title: Monitoring immune-checkpoint blockade: response evaluation and biomarker development
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2017.88
  contributor:
    fullname: Hodi, FS
– volume: 9
  start-page: 17462
  year: 2019
  ident: B36
  article-title: Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-53846-3
  contributor:
    fullname: Ono, Y
– ident: B47
  article-title: Seemann T . 2023 . Snippy: fast bacterial variant calling from NGS reads . https://github.com/tseemann/snippy .
– volume: 8
  start-page: 677720
  year: 2021
  ident: B5
  article-title: Current update on intrinsic and acquired colistin resistance mechanisms in bacteria
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2021.677720
  contributor:
    fullname: Haq, QMR
– volume: 57
  year: 2019
  ident: B31
  article-title: Detection of colistin resistance in Escherichia coli by use of the MALDI Biotyper Sirius mass spectrometry system
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01427-19
  contributor:
    fullname: Larrouy-Maumus, G
– volume: 10
  start-page: 436
  year: 2021
  ident: B33
  article-title: Virulence determinants of colistin-resistant K. pneumoniae high-risk clones
  publication-title: Biology
  doi: 10.3390/biology10050436
  contributor:
    fullname: Can, F
– volume: 88
  year: 2020
  ident: B23
  article-title: mcr-1 gene expression modulates the inflammatory response of human macrophages to Escherichia coli
  publication-title: Infect Immun
  doi: 10.1128/IAI.00018-20
  contributor:
    fullname: Torcia, MG
– volume: 51
  start-page: D690
  issue: (D1)
  year: 2023
  end-page: D699
  ident: B48
  article-title: CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkac920
  contributor:
    fullname: McArthur, AG
– volume: 3
  start-page: 3
  year: 2011
  end-page: 9
  ident: B50
  article-title: Extraction, purification and characterization of lipopolysaccharide from Escherichia coli and Salmonella Typhi
  publication-title: Avicenna J Med Biotechnol
  contributor:
    fullname: Zarnani, AH
– volume: 28
  start-page: 602
  year: 2022
  end-page: 609
  ident: B35
  article-title: Elucidation of molecular mechanism for colistin resistance among Gram-negative isolates from tertiary care hospitals
  publication-title: J Infect Chemother
  doi: 10.1016/j.jiac.2022.01.002
  contributor:
    fullname: Faryal, R
– volume: 8
  start-page: 2054
  year: 2017
  ident: B13
  article-title: Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02149-0
  contributor:
    fullname: Walsh, T
– volume: 8
  start-page: 117
  year: 2010
  end-page: 128
  ident: B15
  article-title: Bacterial manipulation of innate immunity to promote infection
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro2295
  contributor:
    fullname: Gorvel, J-P
– volume: 18
  start-page: 91
  year: 2018
  end-page: 104
  ident: B29
  article-title: Immune checkpoint blockade in infectious diseases
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2017.112
  contributor:
    fullname: Lewin, SR
– volume: 38
  start-page: 227
  year: 2012
  end-page: 242
  ident: B18
  article-title: Bacterial sensing, cell signaling, and modulation of the immune response during sepsis
  publication-title: Shock
  doi: 10.1097/SHK.0b013e318262c4b0
  contributor:
    fullname: Freudenberg, M
– volume: 30
  start-page: 557
  year: 2017
  end-page: 596
  ident: B8
  article-title: Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00064-16
  contributor:
    fullname: Nordmann, P
– volume: 14
  start-page: 449
  year: 2021
  ident: B9
  article-title: Lipid A-Ara4N as an alternate pathway for (colistin) resistance in Klebsiella pneumoniae isolates in Pakistan
  publication-title: BMC Res Notes
  doi: 10.1186/s13104-021-05867-3
  contributor:
    fullname: Hasan, R
– volume: 182
  start-page: 6494
  year: 2009
  end-page: 6507
  ident: B51
  article-title: Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0803350
  contributor:
    fullname: López-Collazo, E
– volume: 6
  start-page: 28
  year: 2017
  ident: B11
  article-title: Interplay between colistin resistance, virulence and fitness in Acinetobacter baumannii
  publication-title: Antibiotics (Basel)
  doi: 10.3390/antibiotics6040028
  contributor:
    fullname: Domingues, S
– volume: 21
  start-page: 4102
  year: 2015
  end-page: 4114
  ident: B26
  article-title: Chemical synthesis of Burkholderia lipid a modified with glycosyl phosphodiester-linked 4-amino-4-deoxy-β-l-arabinose and its immunomodulatory potential
  publication-title: Chemistry
  doi: 10.1002/chem.201406058
  contributor:
    fullname: Zamyatina, A
– volume: 18
  start-page: 18
  year: 2012
  end-page: 29
  ident: B4
  article-title: Colistin: new lessons on an old antibiotic
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2011.03734.x
  contributor:
    fullname: Paul, M
– volume: 19
  start-page: 455
  year: 2012
  end-page: 477
  ident: B45
  article-title: SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing
  publication-title: J Comput Biol
  doi: 10.1089/cmb.2012.0021
  contributor:
    fullname: Pevzner, PA
– volume: 81
  start-page: 430
  year: 2013
  end-page: 440
  ident: B24
  article-title: EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence
  publication-title: Infect Immun
  doi: 10.1128/IAI.01046-12
  contributor:
    fullname: Trent, MS
– volume: 110
  start-page: E4345
  year: 2013
  end-page: E4354
  ident: B20
  article-title: Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1303641110
  contributor:
    fullname: Bernardini, ML
– volume: 72
  start-page: 3035
  year: 2017
  end-page: 3042
  ident: B30
  article-title: Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkx234
  contributor:
    fullname: Doi, Y
– volume: 6
  year: 2011
  ident: B40
  article-title: Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0029577
  contributor:
    fullname: López-Collazo, E
– volume: 9
  start-page: 430
  year: 2017
  end-page: 447
  ident: B22
  article-title: A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.201607336
  contributor:
    fullname: Bengoechea, JA
– volume: 60
  start-page: 1385
  year: 2015
  end-page: 1392
  ident: B6
  article-title: Correlation of β-lactamase production and colistin resistance among Enterobacteriaceae isolates from a global surveillance program
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01870-15
  contributor:
    fullname: Sahm, DF
– volume: 18
  start-page: 630
  year: 2019
  end-page: 635
  ident: B27
  article-title: Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis
  publication-title: J Cyst Fibros
  doi: 10.1016/j.jcf.2018.11.002
  contributor:
    fullname: López-Collazo, E
– volume: 6
  start-page: 48
  year: 2021
  end-page: 58
  ident: B42
  article-title: Potential role of the galectin-9/TIM-3 axis in the disparate progression of SARS-CoV-2 in a married couple: a case report
  publication-title: Biomed Hub
  doi: 10.1159/000514727
  contributor:
    fullname: López-Collazo, E
– volume: 48
  start-page: 614
  year: 2016
  end-page: 621
  ident: B7
  article-title: Epidemiology of infections caused by polymyxin-resistant pathogens
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2016.09.025
  contributor:
    fullname: Giamarellou, H
– volume: 11
  start-page: 467
  year: 2013
  end-page: 481
  ident: B16
  article-title: Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro3047
  contributor:
    fullname: Trent, MS
– volume: 217
  start-page: 393
  year: 2018
  end-page: 404
  ident: B28
  article-title: PD-L1 overexpression during endotoxin tolerance impairs the adaptive immune response in septic patients via HIF1α
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jix279
  contributor:
    fullname: López-Collazo, E
– volume: 71
  start-page: 635
  year: 2002
  end-page: 700
  ident: B1
  article-title: Lipopolysaccharide endotoxins
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.71.110601.135414
  contributor:
    fullname: Whitfield, C
– volume: 93
  start-page: 147
  year: 2019
  end-page: 153
  ident: B32
  article-title: Emergence and dissemination of colistin-resistant Klebsiella pneumoniae isolates expressing OXA-48 plus CTX-M-15 in patients not previously treated with colistin in a Spanish university hospital
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2018.08.014
  contributor:
    fullname: Morosini, M-I
– volume: 13
  start-page: 1525
  year: 2022
  ident: B52
  article-title: The induction of natural competence adapts staphylococcal metabolism to infection
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-29206-7
  contributor:
    fullname: Lopez, D
– volume: 8
  start-page: 1069
  year: 2018
  end-page: 1086
  ident: B39
  article-title: Fundamental mechanisms of immune checkpoint blockade therapy
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-18-0367
  contributor:
    fullname: Allison, JP
– volume: 178
  start-page: 279
  year: 2014
  end-page: 291
  ident: B43
  article-title: Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12401
  contributor:
    fullname: Han, G
– volume: 74
  start-page: 213
  year: 2012
  end-page: 223
  ident: B2
  article-title: Pharmacokinetics and pharmacodynamics of “old” polymyxins: what is new?
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2012.07.010
  contributor:
    fullname: Li, J
– volume: 63
  start-page: 379
  year: 2007
  end-page: 390
  ident: B37
  article-title: Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes
  publication-title: Mol Microbiol
  doi: 10.1111/j.1365-2958.2006.05519.x
  contributor:
    fullname: Gherardini, FC
– volume: 59
  start-page: 6763
  year: 2015
  end-page: 6773
  ident: B12
  article-title: Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00952-15
  contributor:
    fullname: Ko, KS
– volume: 165
  start-page: 891
  year: 2019
  end-page: 904
  ident: B34
  article-title: Absence of the glycosyltransferase WcaJ in Klebsiella pneumoniae ATCC 13883 affects biofilm formation, increases polymyxin resistance and reduces murine macrophage activation
  publication-title: Microbiology (Reading)
  doi: 10.1099/mic.0.000827
  contributor:
    fullname: Ghosh, AS
– ident: e_1_3_3_16_2
  doi: 10.1038/nrmicro2295
– ident: e_1_3_3_53_2
  doi: 10.1038/s41467-022-29206-7
– ident: e_1_3_3_36_2
  doi: 10.1016/j.jiac.2022.01.002
– ident: e_1_3_3_12_2
  doi: 10.3390/antibiotics6040028
– ident: e_1_3_3_20_2
  doi: 10.1128/iai.42.1.170-177.1983
– volume: 3
  start-page: 3
  year: 2011
  ident: e_1_3_3_51_2
  article-title: Extraction, purification and characterization of lipopolysaccharide from Escherichia coli and Salmonella Typhi
  publication-title: Avicenna J Med Biotechnol
  contributor:
    fullname: Rezania S
– ident: e_1_3_3_24_2
  doi: 10.1128/IAI.00018-20
– ident: e_1_3_3_42_2
  doi: 10.1002/ctm2.573
– ident: e_1_3_3_9_2
  doi: 10.1128/CMR.00064-16
– ident: e_1_3_3_29_2
  doi: 10.1093/infdis/jix279
– ident: e_1_3_3_45_2
  doi: 10.1101/gr.074492.107
– ident: e_1_3_3_47_2
  doi: 10.1093/bioinformatics/btu153
– ident: e_1_3_3_43_2
  doi: 10.1159/000514727
– ident: e_1_3_3_34_2
  doi: 10.3390/biology10050436
– ident: e_1_3_3_37_2
  doi: 10.1038/s41598-019-53846-3
– ident: e_1_3_3_46_2
  doi: 10.1089/cmb.2012.0021
– ident: e_1_3_3_30_2
  doi: 10.1038/nri.2017.112
– ident: e_1_3_3_23_2
  doi: 10.15252/emmm.201607336
– ident: e_1_3_3_6_2
  doi: 10.3389/fmed.2021.677720
– ident: e_1_3_3_17_2
  doi: 10.1038/nrmicro3047
– ident: e_1_3_3_33_2
  doi: 10.1016/j.diagmicrobio.2018.08.014
– ident: e_1_3_3_2_2
  doi: 10.1146/annurev.biochem.71.110601.135414
– ident: e_1_3_3_4_2
  doi: 10.1016/S1473-3099(06)70580-1
– ident: e_1_3_3_38_2
  doi: 10.1111/j.1365-2958.2006.05519.x
– ident: e_1_3_3_26_2
  doi: 10.1002/advs.202101336
– ident: e_1_3_3_39_2
  doi: 10.1038/nrclinonc.2017.88
– ident: e_1_3_3_32_2
  doi: 10.1128/JCM.01427-19
– ident: e_1_3_3_18_2
  doi: 10.1007/s00018-014-1762-5
– ident: e_1_3_3_8_2
  doi: 10.1016/j.ijantimicag.2016.09.025
– ident: e_1_3_3_35_2
  doi: 10.1099/mic.0.000827
– ident: e_1_3_3_41_2
  doi: 10.1371/journal.pone.0029577
– ident: e_1_3_3_27_2
  doi: 10.1002/chem.201406058
– ident: e_1_3_3_21_2
  doi: 10.1073/pnas.1303641110
– ident: e_1_3_3_5_2
  doi: 10.1111/j.1469-0691.2011.03734.x
– ident: e_1_3_3_15_2
  doi: 10.1016/j.ijantimicag.2017.11.011
– ident: e_1_3_3_40_2
  doi: 10.1158/2159-8290.CD-18-0367
– ident: e_1_3_3_52_2
  doi: 10.4049/jimmunol.0803350
– ident: e_1_3_3_48_2
– ident: e_1_3_3_22_2
  doi: 10.1016/j.smim.2003.10.003
– ident: e_1_3_3_13_2
  doi: 10.1128/AAC.00952-15
– ident: e_1_3_3_7_2
  doi: 10.1128/AAC.01870-15
– ident: e_1_3_3_28_2
  doi: 10.1016/j.jcf.2018.11.002
– ident: e_1_3_3_3_2
  doi: 10.1016/j.diagmicrobio.2012.07.010
– ident: e_1_3_3_10_2
  doi: 10.1186/s13104-021-05867-3
– ident: e_1_3_3_19_2
  doi: 10.1097/SHK.0b013e318262c4b0
– ident: e_1_3_3_25_2
  doi: 10.1128/IAI.01046-12
– ident: e_1_3_3_31_2
  doi: 10.1093/jac/dkx234
– ident: e_1_3_3_44_2
  doi: 10.1111/cei.12401
– ident: e_1_3_3_49_2
  doi: 10.1093/nar/gkac920
– ident: e_1_3_3_11_2
  doi: 10.1016/j.chembiol.2018.04.003
– ident: e_1_3_3_14_2
  doi: 10.1038/s41467-017-02149-0
– ident: e_1_3_3_50_2
  doi: 10.3791/3916
SSID ssj0014448
Score 2.4739058
Snippet Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect colistin resistance acquisition on...
Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect in vivo colistin resistance...
Colistin resistance is acquired by different lipopolysaccharide (LPS) modifications. We proposed to evaluate the of effect in vivo colistin resistance...
SourceID pubmedcentral
proquest
crossref
asm2
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage e0001223
SubjectTerms Anti-Bacterial Agents - pharmacology
Antimicrobial Chemotherapy
Bacterial Infections
Bacterial Proteins - genetics
Colistin - pharmacology
Cytokines
Drug Resistance, Bacterial - genetics
Humans
Immunity, Innate
Klebsiella Infections - microbiology
Klebsiella pneumoniae
Lipopolysaccharides - pharmacology
Microbial Sensitivity Tests
Title The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification
URI https://www.ncbi.nlm.nih.gov/pubmed/36722977
https://journals.asm.org/doi/10.1128/iai.00012-23
https://search.proquest.com/docview/2771638627
https://pubmed.ncbi.nlm.nih.gov/PMC9933656
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB7RlUBcECyv8pJBcEzbOE5sH1dlV7sSRQj2wC2Kx66ItHUq0h7675nJY0VBXMg1dhJ5xp5vMt_MALwnFGoCepeYNBhyULRNrLchcQRepcPCmYyTky-_6c_fzcdzLpOTj7kwHWkfXT2LN5tZrH903MrtBucjT2z-ZbUkm5oRDplPYELYcHTRh9CBUmo4fum1eaFHtrs087qqZ92vl0Ry_5ys0FIS_qHTuGo38tgy_QU3_2RN_maGLh7CgwE_irP-Ox_BnRBP4W7fUfJwCvdWQ6z8MdSkAeKqS4IUzVosmxvezlF8DS1jRhK2aKIg_CfOcOxxxgOvYiT8STM5cWR3EO4gPtVb7qVwaCvkLK3aB7FqPJOMullP4Pri_Hp5mQyNFZJKpWaX-Bzpsi4UrjDOpU5zNHWxQJsSHlDOYWqrfB08WXtce8wVmoVGcm2URReyp3ASmxieg0BbSYvIdcxQSRWsJ8ng2lQGA2bSTeEdL205bIy27HwOaUoSRR_3LmU2hQ_jwpfbvsbGP8a9HaVS0ibgyEYVQ7NvS6k148pC6ik866V0-6RRylPQR_K7HcAFto_vkN51hbYHPXvx3zNfwn1uT88s77R4BSe7n_vwGiat37_plPYXoz_xqw
link.rule.ids 230,315,729,782,786,887,27934,27935,53802,53804
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB6xi3hceCywlKdBcEzbOE5sH1dlV61oVwh64BbFY1dE2jrVpj303zPOY0VBXDZXexIl39j-JvMC-EQsVDm0JlKxU2SgSB1pq11kiLxyg5lRSUhOnv6Qlz_Vl_NQJiftc2GaoH005dBfrYe-_NXEVm7WOOrjxEbfFhM6UxPiIaMjuEvrdcx7I71zHgghug2YHpxmso9352pUFuWw-fkS8dBBJ8kk58SAaD8u6jU_PJv-IZx_x03-cRBdPL7lKzyBRx3zZGft8FO44_wJ3Gt7Ue5P4P6i87I_g5J0h82a9ElWrdikugobgWffXR3YJqkJqzwj5sjOsO-OFibOvCfmSpIh5WS7Z2bP5uUmdGHY1wWG_K7SOraobAhPaqSew_LifDmZRl1LhqgQsdpGNkW6tHGZyZQxsZHBDzseo46JSQhjMNZFunKWeAKuLKYC1VgiGUVCo3HJCzj2lXcvgaEuuEYMFdBQcOG0pQ-CK1UodJhwM4CPAZK8W1J13lgrXOUEYesxz3kygM89YPmmrc7xn3kfejRzWj7BJ1J4V-3qnEsZGGnG5QBOW3Rv7tRrxwDkAe43E0Jp7sMRgrsp0d3B--rWku_hwXS5mOfz2eXX1_AwNLkPseJx9gaOt9c79xaOart71yj-b0MIB00
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JbtswEB00KRr00iVd4q5s0R5lWRQtksfAiRGjcRC0OfQmiEMaFRBTRmQf_PcdajHqFr20umooQXpD8g1nA_hELFQ5tCZSiVNkoEgdaatdZIi8coOZUWlITr74Jq--q7PzUCZn1-qrCdpHUw797XLoyx9NbOVqiXEfJxZfzye0p6bEQ-KVXcQHcJ_m7Ej0hnrnQBBCdIswvXycyT7mnau4LMphcwAT8dBFJ80k58SCaE0u6iXf35_-IJ2_x07-shlNH__HZzyBRx0DZaetyFO45_wxPGh7Um6P4WjeedufQUk6xGZNGiWrFmxS3YYFwbOvrg6sk9SFVZ4Rg2Sn2HdJC4Iz74nB0siQerLeMrNll-UqdGPY1gWGPK_SOjavbAhTakY9h5vp-c3kIupaM0SFSNQ6smOkSxuXmUwZkxgZ_LGjEeqEGIUwBhNdjBfOEl_AhcWxQDWSSMaR0Ghc-gIOfeXdCTDUBdeIoRIaCi6ctvRTcKEKhQ5TbgbwMcCSd1OrzhurhaucYGw95zlPB_C5By1ftVU6_iL3oUc0p2kUfCOFd9WmzrmUgZlmXA7gZYvw7km9hgxA7mG_EwgluvfvEORNqe4O4lf_PPI9HF2fTfPL2dWX1_Aw9LoPIeNJ9gYO13cb9xYOart51-j-T40YCc0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+Colistin+Resistance+on+the+Activation+of+Innate+Immunity+by+Lipopolysaccharide+Modification&rft.jtitle=Infection+and+immunity&rft.au=Avenda%C3%B1o-Ortiz%2C+Jos%C3%A9&rft.au=Ponce-Alonso%2C+Manuel&rft.au=Llanos-Gonz%C3%A1lez%2C+Emilio&rft.au=Barrag%C3%A1n-Prada%2C+Hugo&rft.date=2023-02-16&rft.eissn=1098-5522&rft.volume=91&rft.issue=2&rft.spage=e0001223&rft.epage=e0001223&rft_id=info:doi/10.1128%2Fiai.00012-23&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon